HomeCompareDMTTF vs FCPT

DMTTF vs FCPT: Dividend Comparison 2026

DMTTF yields 1790.51% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DMTTF wins by $3560995371.95M in total portfolio value
10 years
DMTTF
DMTTF
● Live price
1790.51%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3560995372.00M
Annual income
$3,208,492,995,096,889.00
Full DMTTF calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — DMTTF vs FCPT

📍 DMTTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDMTTFFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DMTTF + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DMTTF pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DMTTF
Annual income on $10K today (after 15% tax)
$152,193.38/yr
After 10yr DRIP, annual income (after tax)
$2,727,219,045,832,355.50/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, DMTTF beats the other by $2,727,219,045,827,446.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DMTTF + FCPT for your $10,000?

DMTTF: 50%FCPT: 50%
100% FCPT50/50100% DMTTF
Portfolio after 10yr
$1780497686.03M
Annual income
$1,604,246,497,551,332.20/yr
Blended yield
90.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

DMTTF
No analyst data
Altman Z
-0.2
Piotroski
1/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DMTTF buys
0
FCPT buys
0
No recent congressional trades found for DMTTF or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDMTTFFCPT
Forward yield1790.51%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$3560995372.00M$49.1K
Annual income after 10y$3,208,492,995,096,889.00$5,775.28
Total dividends collected$3535749756.14M$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: DMTTF vs FCPT ($10,000, DRIP)

YearDMTTF PortfolioDMTTF Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$189,751$179,051.03$11,401$700.92+$178.3KDMTTF
2$3,378,278$3,175,244.60$13,064$864.84+$3.37MDMTTF
3$56,447,685$52,832,927.74$15,051$1,072.48+$56.43MDMTTF
4$885,432,609$825,033,585.64$17,442$1,337.22+$885.42MDMTTF
5$13,042,172,033$12,094,759,140.97$20,340$1,677.08+$13042.15MDMTTF
6$180,452,678,412$166,497,554,336.98$23,880$2,116.57+$180452.65MDMTTF
7$2,346,051,940,236$2,152,967,574,335.48$28,241$2,689.36+$2346051.91MDMTTF
8$28,669,689,008,997$26,159,413,432,944.53$33,660$3,442.07+$28669688.98MDMTTF
9$329,441,473,744,276$298,764,906,504,648.75$40,456$4,439.95+$329441473.70MDMTTF
10$3,560,995,372,003,264$3,208,492,995,096,889.00$49,063$5,775.28+$3560995371.95MDMTTF

DMTTF vs FCPT: Complete Analysis 2026

DMTTFStock

Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. Its clinical program is N,N-dimethyltryptamine assisted therapy to treat major depressive disorder. The company's product includes SPL026 Placebo, which is in clinical Phase IIA for the treatment of major depressive disorder. Its preclinical stage programs include SPL028, a prolonged DMT series; SPL029, an oral DMT series; and SPL801 oral formulation of 6-hydroxynorketamin. The company was incorporated in 2015 and is headquartered in London, the United Kingdom.

Full DMTTF Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this DMTTF vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DMTTF vs SCHDDMTTF vs JEPIDMTTF vs ODMTTF vs KODMTTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.